Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2388798 | 0.98 | HTR2A (0.37) | HTR2AKDM1APDK2MEN1KMT2A | |
| SCHEMBL2390411 | 0.75 | HTR2A (0.44) | HTR2AKDM1ASIGMAR1 | |
| SCHEMBL27511998 | 0.75 | HTR2A (0.44) | HTR2AKDM1ASIGMAR1 | |
| Hydrochloric Acid SCHEMBL2386732 | 0.73 | HTR2A (0.42) | HTR2AKDM1ASIGMAR1 | |
| SCHEMBL12745139 | 0.72 | HTR2A (0.40) | HTR2AKDM1AMEN1KMT2A | |
| SCHEMBL9053415 | 0.72 | HTR2A (0.41) | HTR2AKDM1ASIGMAR1 | |
| SCHEMBL2354334 | 0.70 | HTR2A (0.42) | HTR2AKDM1ASIGMAR1 | |
| SCHEMBL2389396 | 0.69 | KDM1A (0.41) | HTR2AKDM1ASIGMAR1 | |
| SCHEMBL2389607 | 0.69 | HTR2A (0.43) | HTR2AKDM1AKMT2A | |
| SCHEMBL2389059 | 0.69 | HTR2A (0.39) | HTR2AKDM1AMEN1KMT2ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101489984-B | Aminoindan derivative or salt thereof | ASTELLAS PHARMA INC | 2013-04-03 | — | — | CN | disclosed |
| CN-101489984-A | Aminoindan derivative or salt thereof | ASTELLAS PHARMA INC (JP) | 2009-07-22 | — | — | CN | disclosed |